Company intelligence / Profile preview

Chuangxinhui Biotech Venture Capital

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Chuangxinhui Biotech Venture Capital (also known as InnoHub Capital) is a Chinese venture capital firm primarily focused on early-stage investments within the life sciences, biotechnology, and healthcare sectors. The firm specializes in identifying high-potential startups in fields such as innovative drug development, medical devices, and digital health. By providing both financial capital and strategic resources, Chuangxinhui aims to accelerate the commercialization of cutting-edge medical technologies in the Chinese market. The firm often collaborates with academic institutions and industrial parks to foster a robust ecosystem for healthcare innovation.

Industry: Investors

Beyond the preview

Go deeper on Chuangxinhui Biotech Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chuangxinhui Biotech Venture Capital.

Explore the full profile